
Serra Ventures
Description
Serra Ventures is a U.S.-based venture capital firm with a strategic focus on early-stage technology companies, primarily targeting Seed, Seed Plus, and Series A rounds. Headquartered in Champaign, Illinois, the firm extends its investment reach across the Midwest and West Coast, while also engaging with promising startups nationwide. Serra Ventures is known for its hands-on approach, aiming to provide not just capital but also strategic guidance and access to a robust network to support the growth of its portfolio companies.
The firm manages over $100 million in capital across multiple funds, demonstrating a sustained commitment to the venture ecosystem. Their investment thesis centers on disruptive technologies and innovative business models within the software, IT, and broader tech sectors. Serra Ventures has built a significant portfolio, having made over 100 investments since its inception, with a track record of successful exits.
For initial investments, Serra Ventures typically deploys cheques ranging from $250,000 to $1,000,000. This range allows them to be a significant early partner for startups, often participating in larger syndicates for follow-on rounds, where their participation can extend up to $5 million. Their latest funds, including the $45 million Fund V, underscore their continued capacity and intent to back promising ventures at their critical early stages. Serra Ventures positions itself as a long-term partner, committed to fostering innovation and driving value creation for its founders.
Investor Profile
Serra Ventures has backed more than 227 startups, with 2 new investments in the last 12 months alone. The firm has led 44 rounds, about 19% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada, Brazil.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Typical check size: $250K – $1M.
Stage Focus
- Series Unknown (27%)
- Seed (26%)
- Series A (24%)
- Convertible Note (12%)
- Series B (7%)
- Debt Financing (2%)
Country Focus
- United States (96%)
- Canada (1%)
- Brazil (1%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Analytics
- Medical
- Manufacturing
- Saas
- Information Technology
- Medical Device
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.